Pharmacologic Treatment of Schizophrenia, 3E
Robert R. Conley, MD
Chief–Inpatient Research Program,
Professor of Psychiatry, University of Maryland
Chief–Inpatient Research Program,
Professor of Psychiatry, University of Maryland
Deanna L. Kelly, PharmD, BCPP
Associate Professor of Psychiatry,
University of Maryland
Associate Professor of Psychiatry,
University of Maryland
| Availability | In Stock |
|---|---|
| Published | 2007 |
| Length | 288 pages |
| ISBN | 978-1-932610-22-2 |
| Print Price | $24.95 |
| PDF Price | $24.95 |
| Formats | Print, Digital |
About This Book
Antipsychotics are reviewed, including efficacy, adverse effects, pharmacokinetics, mechanisms of action, and dosing. Topics covered include metabolic effects of antipsychotic drugs, mainagement of acute psychosis, long-acting antipsychotic drugs, and treatment-resistant schizophrenia. Pertinent clinical issues in management of this disease are reviewed.